<!--#include file="iHead.inc" --><div class='legisHeader'><header><h1 id='wb-cont' class='HeadTitle'>Food and Drugs Act&#x00A0;(<abbr title='Revised Statutes of Canada'>R.S.C.</abbr>, 1985, c. F-27)</h1><div id='printAll'><p id='FullDoc'>Full Document: &nbsp;</p><ul><li><a href='FullText.html'>HTML<span class='wb-invisible'>Full Document: Food and Drugs Act</span></a>&nbsp;(Accessibility Buttons available) |&nbsp;</li><li><a href='/eng/XML/F-27.xml'>XML<span class='wb-invisible'>Full Document: Food and Drugs Act</span></a> <span class='fileSize'>[<!--#include virtual="/eng/XML/F-27_size.inc"--> KB]</span>&nbsp;|&nbsp;</li> <li><a href='/PDF/F-27.pdf'>PDF<span class='wb-invisible'>Full Document: Food and Drugs Act</span></a> <span class='fileSize'>[<!--#include virtual="/PDF/F-27_size.inc"--> KB]</span></li></ul></div><div class='info'><p id='assentedDate'>Act current to <!--#include file="iConsolDate.inc" --> and <a href='index.html#hist'>last amended</a> on 2021-05-06. <a href='PITIndex.html'>Previous Versions</a></p></div></header><div class='lineSeparator goldLineTop'></div></div><div class='docContents' id='docCont'>
<div class="wb-txthl"><section>
<section><div class="ScheduleRP"><h2 class="scheduleTitleText">RELATED PROVISIONS</h2><ul class="RelatedProvs"><li><p class="nifrpCitation">
          — R.S., 1985, c. 27 (1st Supp.), s. 208</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Writs of Assistance</h6><p class="Section"><span class="lawlabel">208</span> Nothing in sections 190, 195, 199 and 200 of this Act shall be construed as rendering invalid or inadmissible in any proceedings any evidence obtained by the exercise of a writ of assistance prior to the coming into force of those sections.</p></li></ul></li><li><p class="nifrpCitation">
          — 1997, c. 6, s. 66(2)</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Transitional</h6><ul class="Section ProvisionList" id=""><li><p class="Subsection"><span class="lawlabel">66</span> <span class="lawlabel">(2)</span> For greater certainty, the two year limitation period provided for in subsection 32(1) of the Act, as amended by subsection (1), only applies in respect of offences committed after the coming into force of that subsection.</p></li></ul></li></ul></li><li><p class="nifrpCitation">
          — 2005, c. 42, s. 4</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Deeming provision</h6><p class="Section"><span class="lawlabel">4</span> A Notice of Interim Marketing Author­ization that is issued under the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite> before the day on which this section comes into force, in respect of any matter referred to in subsection 30.2(2) of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by section 3 of this Act, and that is in effect on the day on which this section comes into force, is deemed to be an interim marketing authorization issued under subsection 30.2(1) of that Act.</p></li></ul></li><li><p class="nifrpCitation">
          — 2005, c. 42, s. 5(1)</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Pest control products</h6><ul class="Section ProvisionList" id=""><li><p class="Subsection"><span class="lawlabel">5</span> <span class="lawlabel">(1)</span> The maximum residue limit established for an agricultural chemical and its derivatives under the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite>, as those regulations read immediately before the coming into force of this subsection, is deemed, if the agricultural chemical is a pest control product as defined in subsection 2(1) of the <cite class="XRefExternalAct"><a href="/eng/acts/P-9.01">Pest Control Products Act</a></cite>, chapter 28 of the Statutes of Canada, 2002, to have been specified by the Minister under section 9 or 10 of that Act as the maximum residue limit for that agricultural chemical and its derivatives.</p></li></ul></li></ul></li><li><p class="nifrpCitation">
          — 2012, c. 19, s. 417</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Interim marketing authorization</h6><ul class="Section ProvisionList" id=""><li><p class="Subsection"><span class="lawlabel">417</span> <span class="lawlabel">(1)</span> An interim marketing authorization that is issued under subsection 30.2(1) of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite> and in effect immediately before the day on which section 416 comes into force continues to have effect until the earliest of</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> the day on which the Minister of Health publishes a notice cancelling the interim marketing authorization in the <cite class="XRefExternal"><a href="http://www.gazette.gc.ca/">Canada Gazette</a></cite>;</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> the day on which a marketing authorization — or any part of it — that is issued under subsection 30.3(1) of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by section 416, has the same effect as the interim marketing authorization; and</p></li><li><p class="Paragraph"><span class="lawlabel">(c)</span> two years after the day on which the interim marketing authorization is published in the <cite class="XRefExternal"><a href="http://www.gazette.gc.ca/">Canada Gazette</a></cite>.</p></li></ul></li><li><h6 class="MarginalNote">Exemption from <cite class="XRefExternalAct"><a href="/eng/acts/S-22">Statutory Instruments Act</a></cite></h6><p class="Subsection"><span class="lawlabel">(2)</span> A notice cancelling an interim marketing authorization is exempt from sections 3, 5 and 11 of the <cite class="XRefExternalAct"><a href="/eng/acts/S-22">Statutory Instruments Act</a></cite>.</p></li></ul></li></ul></li><li><p class="nifrpCitation">
          — 2014, c. 24, s. 13</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Therapeutic product authorizations</h6><p class="Section"><span class="lawlabel">13</span> The definition <span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span>, as enacted by subsection 2(3), applies to authorizations — including licences and suspended authorizations or licences — that were issued before the day on which this section comes into force and that authorize, as the case may be, the import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage or testing of a therapeutic product.</p></li></ul></li><li><p class="nifrpCitation">
          — 2019, c. 29, s. 180</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Clinical trials — certain drugs</h6><p class="Section"><span class="lawlabel">180</span> A person that, immediately before the coming into force of section 166, is authorized under Division 5 of Part C of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite> to sell or import a drug for the purposes of a clinical trial is deemed to be the holder, in respect of that drug, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p></li></ul></li><li><p class="nifrpCitation">
          — 2019, c. 29, s. 181</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Studies — positron-emitting radiopharmaceuticals</h6><p class="Section"><span class="lawlabel">181</span> A person that, immediately before the coming into force of section 166, is authorized under Division 3 of Part C of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite> to sell or import a positron-emitting radiopharmaceutical for the purposes of a study is deemed to be the holder, in respect of that positron-emitting radiopharmaceutical, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p></li></ul></li><li><p class="nifrpCitation">
          — 2019, c. 29, s. 182</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Clinical trials — natural health products</h6><p class="Section"><span class="lawlabel">182</span> A person that, immediately before the coming into force of section 166, is authorized under Part 4 of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/SOR-2003-196">Natural Health Products Regulations</a></cite> to sell or import a natural health product for the purposes of a clinical trial is deemed to be the holder, in respect of that natural health product, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p></li></ul></li><li><p class="nifrpCitation">
          — 2019, c. 29, s. 183</p><ul class="ProvisionList"><li><h6 class="MarginalNote">Investigational testing — certain medical devices</h6><p class="Section"><span class="lawlabel">183</span> A person that, immediately before the coming into force of section 166, is authorized under Part 3 of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/SOR-98-282">Medical Devices Regulations</a></cite> to sell or import a Class II, III or IV medical device for investigational testing is deemed to be the holder, in respect of the device, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p></li></ul></li></ul></div></section>
</section></div></div><!--END OF DocContents --><div class='lineSeparator goldLineTop'></div>
<section id="right-panel" class="wb-overlay modal-content overlay-def wb-panel-l"><header class="modal-header"><h2 class="modal-title">Table of Contents</h2></header><div class="modal-body"><!--#include file="iToc.inc" --></div></section>
<form class='form-inline goToSection' action='/scripts/gotopage.asp' method='post'><div class='nextPreviousBtnAlign selectTop'><select title='Select page' name='selectPage' class='navSelect'><option value='index'>Table of Contents</option><option value='page-1'>1       ... 3.1</option><option value='page-2'>3.2                       ... 21.3</option><option value='page-3'>21.31                 ... 23</option><option value='page-4'>24            ... 30</option><option value='page-5'>30.1                ... 31.2</option><option value='page-6'>31.3           ... 38</option><option value='page-7'>SCHEDULE A</option><option value='page-8'>SCHEDULE A.1</option><option value='page-9'>SCHEDULE B</option><option value='page-10'>SCHEDULE C</option><option value='page-11'>SCHEDULE D</option><option value='page-12'>SCHEDULE E</option><option value='page-13'>SCHEDULE F</option><option value='page-14'>SCHEDULE G</option><option value='page-15'>SCHEDULE H</option><option value='rpdc' selected='selected'>Related Provisions</option><option value='hist'>Previous Amendments</option></select><input class="button-accent" type='submit' value='Go to page' /><input type='hidden' name='folder' value='F-27'/><input type='hidden' name='type' value='acts' /><input type='hidden' name='language' value='eng'/></div></form>
<!--#include virtual="/includes/gcwu-date-mod-e.inc" -->
</main>
<!--#include virtual="/includes/secmenu_WET4-e.inc" -->
</div>
</div>
<!--#include virtual="/includes/footer_WET4-e.inc" -->
<!--[if gte IE 9 | !IE ]><!-->
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.js"></script>
<script src="/wet-boew/js/wet-boew.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script src="/wet-boew/js/ie8-wet-boew2.js"></script>
<![endif]-->
<script src="/theme-gcwu-fegc/js/theme.js"></script>
<script src="/js/tocCheckjs.js"></script>
</body>
</html>
